D
Arcus Biosciences, Inc. RCUS
$9.34 -$0.20-2.10%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -94.00M -92.00M -93.00M -4.00M -81.00M
Total Depreciation and Amortization 3.00M 2.00M 2.00M 3.00M 3.00M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 14.00M 15.00M 16.00M 36.00M 14.00M
Change in Net Operating Assets -23.00M 101.00M -19.00M -37.00M -24.00M
Cash from Operations -100.00M 26.00M -94.00M -2.00M -88.00M
Capital Expenditure -1.00M -1.00M 0.00 -4.00M -6.00M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 52.00M -28.00M 63.00M -165.00M 34.00M
Cash from Investing 51.00M -29.00M 63.00M -169.00M 28.00M
Total Debt Issued 0.00 47.00M -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 3.00M 2.00M 3.00M 229.00M 3.00M
Repurchase of Common Stock -5.00M -1.00M -1.00M -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -2.00M 48.00M 2.00M 229.00M 3.00M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -51.00M 45.00M -29.00M 58.00M -57.00M
Weiss Ratings